Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP)
Publication
, Conference
Xie, W; Sweeney, C; Regan, M; Nakabayashi, M; Buyse, M; Clarke, N; Collette, L; Dignam, J; Fizazi, K; Habibian, M; Halabi, S; Kantoff, P ...
Published in: ANNALS OF ONCOLOGY
October 1, 2016
Duke Scholars
Published In
ANNALS OF ONCOLOGY
DOI
EISSN
1569-8041
ISSN
0923-7534
Publication Date
October 1, 2016
Volume
27
Location
Copenhagen, DENMARK
Publisher
OXFORD UNIV PRESS
Conference Name
41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Xie, W., Sweeney, C., Regan, M., Nakabayashi, M., Buyse, M., Clarke, N., … Williams, S. (2016). Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP). In ANNALS OF ONCOLOGY (Vol. 27). Copenhagen, DENMARK: OXFORD UNIV PRESS. https://doi.org/10.1093/annonc/mdw372.1
Xie, W., C. Sweeney, M. Regan, M. Nakabayashi, M. Buyse, N. Clarke, L. Collette, et al. “Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP).” In ANNALS OF ONCOLOGY, Vol. 27. OXFORD UNIV PRESS, 2016. https://doi.org/10.1093/annonc/mdw372.1.
Xie W, Sweeney C, Regan M, Nakabayashi M, Buyse M, Clarke N, et al. Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP). In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016.
Xie, W., et al. “Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP).” ANNALS OF ONCOLOGY, vol. 27, OXFORD UNIV PRESS, 2016. Wos, doi:10.1093/annonc/mdw372.1.
Xie W, Sweeney C, Regan M, Nakabayashi M, Buyse M, Clarke N, Collette L, Dignam J, Fizazi K, Habibian M, Halabi S, Kantoff P, Parulekar W, Sandler HM, Sartor O, Soule H, Sydes M, Tombal B, Williams S. Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP). ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016.
Published In
ANNALS OF ONCOLOGY
DOI
EISSN
1569-8041
ISSN
0923-7534
Publication Date
October 1, 2016
Volume
27
Location
Copenhagen, DENMARK
Publisher
OXFORD UNIV PRESS
Conference Name
41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis